Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Endocrine Therapy Interruption in Increasing Risk of Recurrence in Younger Patients with Hormone Receptor-Positive, Stage I-III Breast Cancer Who Desire Pregnancy

Trial Status: closed to accrual and intervention

This clinical trial studies endocrine therapy interruption in increasing risk of recurrence in younger patients with hormone receptor-positive, stage I-III breast cancer who desire pregnancy. Stopping endocrine therapy temporarily, with the goal of permitting pregnancy, may increase risk of breast cancer recurrence.